xinliwei cefepime hydrochloride injection 0

Description

Indication & Scope

XinLiWei® (Cefepime Hydrochloride for Injection) is a prescription fourth-generation cephalosporin antibiotic indicated for the treatment of moderate to severe infections caused by susceptible bacteria in adults and pediatric patients. It is commonly used for pneumonia, urinary tract infections, skin and soft tissue infections, intra-abdominal infections, septicemia, febrile neutropenia, and pediatric bacterial meningitis. Cefepime provides broad-spectrum activity against both Gram-positive and Gram-negative pathogens, including Pseudomonas aeruginosa.

Mechanism: Cefepime inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), resulting in bacterial cell death.
Drug class: Fourth-generation cephalosporin antibiotic.
Clinical use: Treatment of moderate to severe susceptible bacterial infections, including hospital-acquired infections and empiric therapy for febrile neutropenia.

Specification

Generic Name	Cefepime Hydrochloride for Injection
Brand Name	XinLiWei®
Ingredient	Cefepime Hydrochloride
Dosage Form	Injection
Package	0.5 g/vial
Conditions Treated	Pneumonia, urinary tract infections, skin and soft tissue infections, intra-abdominal infections, septicemia, febrile neutropenia, and bacterial meningitis
Taboos	Hypersensitivity to cefepime, cephalosporins, penicillins, or other β-lactam antibiotics
Place of origin	China
Prescription type	Prescription Drug (Rx)
Storage Conditions	Store below 20°C in a dry place protected from light. Do not freeze.
Manufacturer	Shenzhen Salubris Pharmaceuticals Co., Ltd.
Registration Authority	National Medical Products Administration (NMPA), China
Approval Number	H20041631
Approval Date	May 28, 2024
Shelf Life	24 months

How to use ?

Recommended Dose: Adults generally receive 0.5–2 g every 12 hours. Severe infections or febrile neutropenia may require 2 g every 8 hours.

Time: Administer every 8–12 hours according to the type and severity of infection. Treatment duration is usually 7–14 days.

Instructions for use: Administer by intramuscular injection or intravenous infusion. Dosage adjustment is required in patients with renal impairment.

Interaction: Use cautiously with aminoglycosides, loop diuretics, anticoagulants, and other nephrotoxic agents.

Side effects: Injection-site reactions, diarrhea, nausea, rash, headache, elevated liver enzymes, and hypersensitivity reactions.

Important Notice

This product should be administered only by qualified healthcare professionals in accordance with the approved prescribing information and local clinical guidelines. Dosage and administration may vary depending on patient condition, indication, and regional regulatory requirements.

Packaging & Shipping

Packaging

Original manufacturer’s packaging with secure export carton. Customized export packaging is available upon request.

Shipping Methods

Express Courier (EMS, DHL, FedEx, UPS), Air Freight, and Sea Freight. Cold-chain transportation is available for products requiring temperature-controlled logistics.

Export Support

Certificate of Analysis

GMP Certificate

Commercial Invoice

Packing List & CPP

Cold Chain Logistics

Customs Documentation

Scientific and regulatory sources

1.WHO References

2.NMPA

3.FDA

4.EMA

FAQ

What is XinLiWei® used for?

XinLiWei® is used to treat moderate to severe bacterial infections, including pneumonia, urinary tract infections, septicemia, intra-abdominal infections, and bacterial meningitis.

Does XinLiWei® cover Pseudomonas aeruginosa?

Yes. Cefepime has excellent activity against Pseudomonas aeruginosa and many other Gram-negative bacteria.

How is XinLiWei® administered?

It is administered by intramuscular injection or intravenous infusion under medical supervision.

Can patients with kidney disease use XinLiWei®?

Yes, but the dosage should be adjusted according to renal function to reduce the risk of adverse reactions.